These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 30168487)

  • 1. The
    Devaraju P; Mehra S; Gulati R; Antony PT; Jain VK; Misra DP; Negi VS
    Indian J Med Res; 2018 Jun; 147(6):560-566. PubMed ID: 30168487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interferon regulatory factor 5 gene polymorphism in Egyptian children with systemic lupus erythematosus.
    Hammad A; Mossad YM; Nasef N; Eid R
    Lupus; 2017 Jul; 26(8):871-880. PubMed ID: 28059021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of IRF5 rs2004640 polymorphism and systemic lupus erythematosus: A meta-analysis.
    Wang JM; Huang AF; Yuan ZC; Su LC; Xu WD
    Int J Rheum Dis; 2019 Sep; 22(9):1598-1606. PubMed ID: 31347288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between the rs2004640 functional polymorphism of interferon regulatory factor 5 and systemic lupus erythematosus: a meta-analysis.
    Lee YH; Song GG
    Rheumatol Int; 2009 Aug; 29(10):1137-42. PubMed ID: 19043711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between the interferon regulatory factor 5 rs2004640 functional polymorphism and systemic lupus erythematosus: an updated meta-analysis.
    Bae SC; Lee YH
    Lupus; 2019 May; 28(6):740-747. PubMed ID: 31018759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of a common interferon regulatory factor 5 (IRF5) variant with increased risk of systemic lupus erythematosus (SLE).
    Demirci FY; Manzi S; Ramsey-Goldman R; Minster RL; Kenney M; Shaw PS; Dunlop-Thomas CM; Kao AH; Rhew E; Bontempo F; Kammerer C; Kamboh MI
    Ann Hum Genet; 2007 May; 71(Pt 3):308-11. PubMed ID: 17166181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of IRF5 polymorphisms with increased risk for systemic lupus erythematosus in population of Crete, a southern-eastern European Greek island.
    Zervou MI; Dorschner JM; Ghodke-Puranik Y; Boumpas DT; Niewold TB; Goulielmos GN
    Gene; 2017 Apr; 610():9-14. PubMed ID: 28185859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A meta-analysis of the association of IRF5 polymorphism with systemic lupus erythematosus.
    Hu W; Ren H
    Int J Immunogenet; 2011 Oct; 38(5):411-7. PubMed ID: 21834935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of interferon regulatory factor 5 (IRF5) markers with an increased risk of lupus and overlapping autoimmunity in a Kuwaiti population.
    AlFadhli S; Jahabani I
    Ann Hum Biol; 2014; 41(6):531-9. PubMed ID: 24697591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of IRF5 gene polymorphisms and lupus nephritis in a Chinese population.
    Qin L; Lv J; Zhou X; Hou P; Yang H; Zhang H
    Nephrology (Carlton); 2010 Oct; 15(7):710-3. PubMed ID: 21040166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic association and interaction between the IRF5 and TYK2 genes and systemic lupus erythematosus in the Han Chinese population.
    Tang L; Wan P; Wang Y; Pan J; Wang Y; Chen B
    Inflamm Res; 2015 Oct; 64(10):817-24. PubMed ID: 26294277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of an IRF5 gene functional polymorphism with Sjögren's syndrome.
    Miceli-Richard C; Comets E; Loiseau P; Puechal X; Hachulla E; Mariette X
    Arthritis Rheum; 2007 Dec; 56(12):3989-94. PubMed ID: 18050197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comprehensive evaluation of the genetic variants of interferon regulatory factor 5 (IRF5) reveals a novel 5 bp length polymorphism as strong risk factor for systemic lupus erythematosus.
    Sigurdsson S; Göring HH; Kristjansdottir G; Milani L; Nordmark G; Sandling JK; Eloranta ML; Feng D; Sangster-Guity N; Gunnarsson I; Svenungsson E; Sturfelt G; Jönsen A; Truedsson L; Barnes BJ; Alm G; Rönnblom L; Syvänen AC
    Hum Mol Genet; 2008 Mar; 17(6):872-81. PubMed ID: 18063667
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IRF5 haplotypes demonstrate diverse serological associations which predict serum interferon alpha activity and explain the majority of the genetic association with systemic lupus erythematosus.
    Niewold TB; Kelly JA; Kariuki SN; Franek BS; Kumar AA; Kaufman KM; Thomas K; Walker D; Kamp S; Frost JM; Wong AK; Merrill JT; Alarcón-Riquelme ME; Tikly M; Ramsey-Goldman R; Reveille JD; Petri MA; Edberg JC; Kimberly RP; Alarcón GS; Kamen DL; Gilkeson GS; Vyse TJ; James JA; Gaffney PM; Moser KL; Crow MK; Harley JB
    Ann Rheum Dis; 2012 Mar; 71(3):463-8. PubMed ID: 22088620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A common haplotype of interferon regulatory factor 5 (IRF5) regulates splicing and expression and is associated with increased risk of systemic lupus erythematosus.
    Graham RR; Kozyrev SV; Baechler EC; Reddy MV; Plenge RM; Bauer JW; Ortmann WA; Koeuth T; González Escribano MF; ; Pons-Estel B; Petri M; Daly M; Gregersen PK; Martín J; Altshuler D; Behrens TW; Alarcón-Riquelme ME
    Nat Genet; 2006 May; 38(5):550-5. PubMed ID: 16642019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interferon regulatory factor 5 gene polymorphism confers risk to several rheumatic diseases and correlates with expression of alternative thymic transcripts.
    Nordang GB; Viken MK; Amundsen SS; Sanchez ES; Flatø B; Førre OT; Martin J; Kvien TK; Lie BA
    Rheumatology (Oxford); 2012 Apr; 51(4):619-26. PubMed ID: 22179739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IRF5 rs2004640-T allele, the new genetic factor for systemic lupus erythematosus, is not associated with rheumatoid arthritis.
    Garnier S; Dieudé P; Michou L; Barbet S; Tan A; Lasbleiz S; Bardin T; Prum B; Cornélis F
    Ann Rheum Dis; 2007 Jun; 66(6):828-31. PubMed ID: 17158136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic variants and disease-associated factors contribute to enhanced interferon regulatory factor 5 expression in blood cells of patients with systemic lupus erythematosus.
    Feng D; Stone RC; Eloranta ML; Sangster-Guity N; Nordmark G; Sigurdsson S; Wang C; Alm G; Syvänen AC; Rönnblom L; Barnes BJ
    Arthritis Rheum; 2010 Feb; 62(2):562-73. PubMed ID: 20112383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural insertion/deletion variation in IRF5 is associated with a risk haplotype and defines the precise IRF5 isoforms expressed in systemic lupus erythematosus.
    Kozyrev SV; Lewén S; Reddy PM; Pons-Estel B; ; Witte T; ; Junker P; Laustrup H; Gutiérrez C; Suárez A; Francisca González-Escribano M; Martín J; ; Alarcón-Riquelme ME
    Arthritis Rheum; 2007 Apr; 56(4):1234-41. PubMed ID: 17393452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of the IRF5 risk haplotype with high serum interferon-alpha activity in systemic lupus erythematosus patients.
    Niewold TB; Kelly JA; Flesch MH; Espinoza LR; Harley JB; Crow MK
    Arthritis Rheum; 2008 Aug; 58(8):2481-7. PubMed ID: 18668568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.